Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-Plus: a double-blind, randomised, placebo-controlled phase 3 clinical trial-Reference-Cited by-同舟云学术

Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-Plus: a double-blind, randomised, placebo-controlled phase 3 clinical trial

Published:2023-02 Issue: Volume:18 Page:100423
ISSN:2667-193X
Container-title:The Lancet Regional Health - Americas
language:en
Short-container-title:The Lancet Regional Health - Americas

Author:

Toledo-Romaní María Eugenia,García-Carmenate Mayra,Valenzuela-Silva Carmen,Baldoquín-Rodríguez Waldemar^ORCID,Martínez-Pérez Marisel,Rodríguez-González Meiby,Paredes-Moreno Beatriz,Mendoza-Hernández Ivis,González-Mujica Romero Raúl,Samón-Tabio Oscar,Velazco-Villares Pablo,Bacallao-Castillo Juan Pablo,Licea-Martín Ernesto,Rodríguez-Ortega Misladys,Herrera-Marrero Nuris,Caballero-González Esperanza,Egües-Torres Liudmila,Duartes-González Reinaldo,García-Blanco Serguey,Pérez-Cabrera Suzette,Huete-Ferreira Santos,Idalmis-Cisnero Kirenia,Fonte-Galindo Omayda,Meliá-Pérez Dania,Rojas-Remedios Ivonne,Doroud Delaram,Gouya Mohammad Mehdi,Biglari Alireza,Fernández-Castillo Sonsire,Climent-Ruiz Yanet,Valdes-Balbín Yury,García-Rivera Dagmar^ORCID,Van der Stuyft Patrick,Verez-Bencomo Vicente^ORCID

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Internal Medicine,Health Policy

Reference31 articles.

1. SARS-CoV-2 variants and vaccines;Krause;N Engl J Med,2021

2. Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis;Rotshild;Sci Rep,2021

3. SARS-CoV-2 RBD-tetanus toxoid conjugate vaccine induces a strong neutralising immunity in preclinical studies;Valdes-Balbin;ACS Chem Biol,2021

4. Haemophilus influenzae type B polysaccharide-protein conjugates: model for a new generation of capsular polysaccharide vaccines;Schneerson;Prog Clin Biol Res,1980

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Immunological Memory: Unveiling Booster Doses to Bolster Vaccine Efficacy Against Evolving SARS-CoV-2 Mutant Variants;Current Microbiology;2024-02

2. To be remembered: B cell memory response against SARS‐CoV‐2 and its variants in vaccinated and unvaccinated individuals;Scandinavian Journal of Immunology;2023-12-06

3. BioHabana 2022: Preventive and Immunotherapeutic Strategies Against COVID-19 and Cancer in Cuba;Journal of Interferon & Cytokine Research;2023-12-01

4. Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster;eBioMedicine;2023-12

5. A Review of COVID-19 Vaccines, Immunogenicity, Safety, and Efficacy Toward Addressing Vaccine Hesitancy, Inequity, and Future Epidemic Preparedness;Epidemic Preparedness and Control [Working Title];2023-11-03